ProFunds > ProFunds
ProFund VP Pharmaceuticals
$11.38M
Avg Monthly Net Assets
$9.65M
Total Assets
$205K
Total Liabilities
$9.44M
Net Assets
ProFund VP Pharmaceuticals is an Underlying fund in ProFunds
from ProFunds,
based in Maryland,
United States of America.
The fund has one share class
and monthly net assets of $11.38M.
On August 27th, 2024 it reported 51 holdings, the largest
being AXSOME THERAPEUTICS, INC. (4.2%), VIATRIS INC. (4.0%) and ELI LILLY AND COMPANY (4.0%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| ProFund VP Pharmaceuticals | C000011102 |
Holdings
From latest NPORT-P, filed August 27th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| AMNEAL PHARMACEUTICALS INC (AMNEAL PHARMACEUTICALS, INC.) | Long | Equity-common | US | $98K | 15K | 1.04 |
| AMPHASTAR PHARMACEUTICALS INC | Long | Equity-common | US | $207K | 5K | 2.19 |
| ANI PHARMACEUTICALS INC (ANI PHARMACEUTICALS, INC.) | Long | Equity-common | US | $136K | 2K | 1.44 |
| ARVINAS INC | Long | Equity-common | US | $313K | 12K | 3.31 |
| AXSOME THERAPEUTICS INC (AXSOME THERAPEUTICS, INC.) | Long | Equity-common | US | $396K | 5K | 4.19 |
| BRISTOL MYERS SQUIBB CO (BRISTOL-MYERS SQUIBB COMPANY) | Long | Equity-common | US | $365K | 9K | 3.86 |
| CASSAVA SCIENCES INC (CASSAVA SCIENCES, INC.) | Long | Equity-common | US | $125K | 10K | 1.32 |
| CATALENT INC (CATALENT, INC.) | Long | Equity-common | US | $367K | 7K | 3.89 |
| COLLEGIUM PHARMACEUTICAL INC (Collegium Pharmaceutical, Inc.) | Long | Equity-common | US | $182K | 6K | 1.93 |
| CORCEPT THERAPEUTICS INC (CORCEPT THERAPEUTICS INCORPORATED) | Long | Equity-common | US | $334K | 10K | 3.53 |
| CREDIT AGRICOLE CIB NY | Long | Repurchase agreement | US | $27K | – | 0.29 |
| EDGEWISE THERAPEUTICS INC | Long | Equity-common | US | $143K | 8K | 1.52 |
| ELANCO ANIMAL HEALTH INC (ELANCO ANIMAL HEALTH INCORPORATED) | Long | Equity-common | US | $290K | 20K | 3.07 |
| ELI LILLY CO (ELI LILLY AND COMPANY) | Long | Equity-common | US | $374K | 413 | 3.96 |
| ENLIVEN THERAPEUTICS INC | Long | Equity-common | US | $68K | 3K | 0.72 |
| EVOLUS INC | Long | Equity-common | US | $95K | 9K | 1.00 |
| EYEPOINT PHARMACEUTICALS INC (EYEPOINT PHARMACEUTICALS, INC.) | Long | Equity-common | US | $82K | 9K | 0.87 |
| FULCRUM THERAPEUTICS INC | Long | Equity-common | US | $48K | 8K | 0.51 |
| HARMONY BIOSCIENCES HOLDINGS INC (HARMONY BIOSCIENCES HOLDINGS, INC.) | Long | Equity-common | US | $145K | 5K | 1.53 |
| HARROW INC (HARROW, INC.) | Long | Equity-common | US | $74K | 4K | 0.78 |
| HSBC SECURITIES USA INC | Long | Repurchase agreement | US | $52K | – | 0.55 |
| INNOVIVA INC (INNOVIVA, INC.) | Long | Equity-common | US | $114K | 7K | 1.21 |
| INTRA CELLULAR THERAPIES INC (Intra-Cellular Therapies Inc) | Long | Equity-common | US | $366K | 5K | 3.87 |
| Invesco Government & Agency Portfolio (AGPXX) | Short-term investment vehicle | US | $182K | 182K | 1.93 | |
| JAZZ PHARMACEUTICALS PLC (JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY) | Long | Equity-common | IE | $342K | 3K | 3.62 |
| JOHNSON JOHNSON (JOHNSON & JOHNSON) | Long | Equity-common | US | $364K | 2K | 3.85 |
| LIGAND PHARMACEUTICALS (LIGAND PHARMACEUTICALS INCORPORATED) | Long | Equity-common | US | $158K | 2K | 1.67 |
| LIQUIDIA TECHNOLOGIES INC (Liquidia Corp) | Long | Equity-common | US | $128K | 11K | 1.35 |
| LONGBOARD PHARMACEUTICALS INC | Long | Equity-common | US | $140K | 5K | 1.49 |
| MERCK COMPANY INC (MERCK & CO., INC.) | Long | Equity-common | US | $346K | 3K | 3.67 |
| MIND MEDICINE MINDMED INC (Mind Medicine (MindMed) Inc) | Long | Equity-common | CA | $112K | 16K | 1.19 |
| NATWEST MARKETS PLC | Long | Repurchase agreement | US | $24K | – | 0.25 |
| NUVATION BIO INC | Long | Equity-common | US | $42K | 15K | 0.45 |
| OCULAR THERAPEUTIX INC (OCULAR THERAPEUTIX, INC.) | Long | Equity-common | US | $219K | 32K | 2.32 |
| ORGANON CO (ORGANON & CO.) | Long | Equity-common | US | $367K | 18K | 3.89 |
| PACIRA BIOSCIENCES INC (PACIRA BIOSCIENCES, INC.) | Long | Equity-common | US | $191K | 7K | 2.02 |
| PERRIGO CO PLC (PERRIGO COMPANY PUBLIC LIMITED COMPANY) | Long | Equity-common | IE | $346K | 13K | 3.67 |
| PFIZER INC (PFIZER INC.) | Long | Equity-common | US | $368K | 13K | 3.90 |
| PLIANT THERAPEUTICS INC | Long | Equity-common | US | $56K | 5K | 0.60 |
| PRESTIGE CONSUMER HEALTHCARE INC (PRESTIGE CONSUMER HEALTHCARE INC.) | Long | Equity-common | US | $227K | 3K | 2.40 |
| ROYAL BANK OF CANADA | Long | Repurchase agreement | US | $16K | – | 0.17 |
| ROYALTY PHARMA PLC | Long | Equity-common | GB | $355K | 13K | 3.76 |
| SOCIETE GENERALE | Long | Repurchase agreement | US | $42K | – | 0.44 |
| SUPERNUS PHARMACEUTICALS INC (SUPERNUS PHARMACEUTICALS, INC.) | Long | Equity-common | US | $183K | 7K | 1.94 |
| TARSUS PHARMACEUTICALS INC | Long | Equity-common | US | $183K | 7K | 1.93 |
| TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. SELECT PHARMACEUTICALS INDEX | Derivative-equity | US | $-4K | – | -0.04 | |
| UMB FINANCIAL CORP | Long | Repurchase agreement | US | $4K | – | 0.04 |
| VIATRIS INC (VIATRIS INC.) | Long | Equity-common | US | $378K | 36K | 4.01 |
| WAVE LIFE SCIENCES LTD | Long | Equity-common | SG | $36K | 7K | 0.38 |
| XERIS BIOPHARMA HOLDINGS INC (XERIS BIOPHARMA HOLDINGS, INC.) | Long | Equity-common | US | $39K | 18K | 0.42 |
| ZOETIS INC (ZOETIS INC.) | Long | Equity-common | US | $368K | 2K | 3.90 |
Address
ProFunds
7272 Wisconsin Avenue
21st Floor
Bethesda
Maryland
20814
United States of America
Websites
Directors
William D. Fertig
Russell S. Reynolds, III
Michael C. Wachs
Michael L. Sapir
Transfer Agents
FIS Investor Services LLC
Pricing Services
Bloomberg L.P.
Refinitiv US Holdings, Inc.
ICE Data Services
Custodians
UMB Bank, N.A.
Shareholder Servicing Agents
ProFunds Distributors, Inc.
Admins
Citi Fund Services Ohio, Inc.
Brokers
N/A